clindamycin
Commercial- Indications
- Staphylococcal bone infections, Joint infections, Chronic sinusitis, Lower respiratory tract infections
Company intelligence / Profile preview
ACS Dobfar
Tribiano, Lombardy, Italyacsdobfar.it ↗
- Ownership
- Private
- Employees
- ~940
- Development stage
- Commercial
01
Overview
ACS Dobfar has a robust commercial portfolio of anti-infective APIs and finished dosage forms. The company supplies products globally with a focus on cephalosporin, carbapenem, and penicillin antibiotics. It operates under strict quality standards with regular inspections by European and US authorities.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
1 asset03
Partnerships
Trusted partnerships with global pharmaceutical companies
Beyond the preview
Go deeper on ACS Dobfar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACS Dobfar.